Fortetropin supplementation prevents the rise in circulating myostatin but not disuse-induced muscle atrophy in young men with limb immobilization: A randomized controlled trial
Fig 2
The absolute value of vastus lateralis CSA (A) and lower limb LM (C) of the immobilized leg at each phase, and the percentage change in vastus lateralis CSA (B) and lower limb LM (D) during each phase. Boxes represent the 25th to 75th percentile, with the central horizontal lines indicating the median. The whiskers represent the maximum and minimum values, and the cross represents the mean value. FOR-SUPP, Fortetropin® supplement; PLA-SUPP, placebo supplement; CSA, cross-sectional area; LM, lean mass. * P < 0.05, significant difference from Day 1 and 14 (main effect), # P < 0.05, significant difference from run-in (main effect).